Population Pharmacokinetic (PK)-Pharmacodynamic (PD) (PKPD) models are increasingly used in drug 25 development and in academic research. Hence designing efficient studies is an important task. 26
Introduction 42
Estimation of pharmacokinetic (PK) parameters for an individual using nonlinear regression 43 techniques started in the 1960's, followed by estimation of dose-response and of pharmacodynamics 44 (PD) models. At around the same time mathematical approaches to defining the problem of optimal 45 design for parameter estimation in nonlinear regression was addressed (1-3). However this did not 46 reach the PK literature until some 20 years later (4). The problem was not only to draw inference 47 from data but also to define the best design(s) for estimation of parameters using maximum 48 likelihood or other estimation methods. For this purpose, the Fisher Information matrix (FIM) was 49 used to describe the informativeness of a design, i.e. how much information the design has in 50 relation to parameter estimation. Typically in PK the FIM is summarized by its determinant and 51 maximising the determinant, termed D-optimality, is equivalent to minimising the asymptotic 52 confidence region of the parameters, i.e. getting the most precise parameter estimates (5) (6) (7) (8) (9) . 53 However, beyond theoretical developments, a limitation of individualised optimised designs of PKPD 54 studies is that those designs do not acknowledge population information and hence cannot have 55 fewer sampling times per individual than parameters to estimate. In addition, optimal designs with a 56 large number of observations per patient will have replicated optimal sampling times; which were 57 not favoured by pharmacologists interested in exploring complex PK models. Some later work also 58 explored Bayesian designs, where a priori distributions of the parameters were considered, and 59 individual parameters were estimated using maximum a posteriori probability (MAP). Optimal 60 designs for MAP estimation optimise individual designs given prior population information and are 61 suitable for e.g. therapeutic drug monitoring designs (10, 11) . Since 1985, the software Adapt 62 (https://bmsr.usc.edu/software/adapt/) has included methods for optimal design in nonlinear 63 regression using several criteria for MAP estimation. 64
The population approach was introduced by Sheiner et al. (12) for PK analyses in the late 1970's and 65 since the 1980's there has been a large increase in the use of this approach as well as extensions to 66 PKPD. Estimation was mainly based on maximum likelihood using nonlinear mixed effects models 67 (NLMEM) thanks to the software NONMEM. To our knowledge the first article studying the impact of 68 a 'population design' on properties of estimates was performed in early 1990's by Al Banna et al. (13) 69 for a population PK and a population PKPD example. In this work the author used clinical trial 70 simulation (CTS) to explore possible designs. The authors studied the influence of the balance of 71 number of patients, number of sampling times and locations of the sampling times on the precision 72 of the parameter estimates. Several papers, all using CTS, were published (14) (15) (16) showing that some 73 designs could be rather poor, and that very sparse designs also performed poorly. The FDA's 74 4 Guidance for Industry Population Pharmacokinetics (17) from 1999 includes a specific section on 75 design, and suggests that simulation, based on preliminary information, should be performed to 76 "anticipate certain fatal study designs, and to recognize informative ones". 77
Using CTS for design evaluation requires a large number of data sets to be simulated and then fitted 78 under each proposed design which is computationally expensive. However, since CTS is a user driven, 79 heuristic approach, then it can miss important regions of the design space because only a fixed 80 number of designs are investigated. Subsequently it was suggested to use the FIM in NLMEM to 81 predict asymptotic standard errors (SE) and define optimal designs without the need for intensive 82 simulations. Because the population likelihood has no closed-form expression the proposed 83 approach for defining the population FIM was to use a first-order linearisation of the model around 84 the random effects (which is the same as used for the first-order (FO) estimation methods). This 85 approximation results in a mixed effect model where the random effects enter the model linearly 86 (rather than nonlinearly) and hence has properties that are similar to linear mixed effects model. The 87 expression for the population FIM was first published in Biometrika in 1997 (18) . In this work the FIM 88 was derived for a population PK example and an algorithm was proposed to optimise designs based 89 on the population FIM. This paper launched the new field of optimal design for nonlinear mixed 90 effects models. It has been quoted in the section 'other influential papers of the 1990's' in a review 91
in Biometrika (19) . 92
Since 1997 several methodological papers from various academic teams have published different 93 extensions, for instance robust designs, sampling windows, compound designs, multiple response 94 models, methods for discrete longitudinal data, and other approximations of the FIM, etc. Most 95 importantly, the derivation of the expression of the FIM was implemented in several software tools, 96 the first one PFIM (20) in 2001 appeared simultaneously in both R (http://www.r-project.org/) and 97 Matlab (http://www.mathworks.fr/products/matlab/). This was followed by POPT (21), and later to 98 incorporate an interface version WinPOPT, PopED (22) , PopDes (23) and PkStaMp (24). There are 99 now five different software tools, all implementing the first-order approximation, with some tools 100 implementing one or several other approximations. These tools for designing population PKPD 101 studies are gaining popularity. In a recent study performed among European Federation of 102 Pharmaceutical Industries and Associations members' (25), it was found that 9 out of 10 103 pharmaceutical companies are using one of these software tools for design evaluation or 104 optimisation, mainly in phases I and II. 105
5
The computation of the FIM is complex and depends on the numerical implementation. The purpose 106 of the present work was therefore to compare the results provided by those different software tools 107 in terms of FIM and predicted SE values. The same basic approximations were used in each software, 108 and the comparison was performed for two examples: (1) a simple PK example described by a one-109 compartment model with first-order absorption and linear elimination and (2) a more complex PKPD 110 example where the PD component is defined by a system of nonlinear ordinary differential equations 111 (ODE). The objective was to explore the results from different software tools and to compare results 112 against those obtained using CTS. We wanted to show the user community that similar results would 113 be obtained with any software tool although programmed in different languages and by different 114 authors. This was also studied in the case of a multiple responses ODE model where the numerical 115 imbrication between ODE solver and numerical differentiation is complex. The results were provided 116 by the software developers, all authors of this article, who were given the equations of the models, 117 the values of the parameters and the designs to be evaluated. Results were compared to those 118 obtained by CTS. 119
The article is organized as follows: first the description of the population FIM for NLMEM, second a 120 description of the various software tools, and then an evaluation of the two examples. As no design 121 optimisation was performed in the present study, no optimisation characteristics or algorithms are 122 described. be constant between observations, e.g. the drug dose, or vary between observations, e.g. the times 136 at which the response variable is measured. 137
An elementary design l ξ can be the same within a group l of l N subjects ( 1, , l L = … ). Using a 138 similar notation for the complete population design Ξ in a limited number of L groups of different , , ,
is the vector of n ik observations for subject i and response k modelled as 148 ε is the residual error vector for response k in subject i. In this paper additive 152 (homoscedastic) or proportional (heteroscedastic) error models will be used in the examples so that 153 only one residual variance parameter is defined for each response. To simplify notation we assume 154 that ik ε are normally distributed and independent between responses (which is not necessary, see 155 e.g. (26, 27)) with mean zero and variance Σ k =diag( 2 k σ ). The individual parameter vector i θ , with 156 parameter(s) that might be shared between responses, is described as 157
where β is the u-vector of fixed effects parameters, or typical subject parameter and b i , the vector 159 of the v random effects for the subject i defining the subject deviation from the typical value of the 160 parameter. We assume that b i is normally distributed with a mean of zero and a covariance matrix 161 Ω of size × . Again, to simplify notation we assume a diagonal (which is not necessary, see e.g. 162 (18, (27) (28) (29) ) interindividual covariance matrix ( Ω ) with diagonal elements ( 2 2 1 ,..., v ω ω ). The vector of 163 population parameters is thus defined as 164
 is the vector of all variance components.
166
The population Fisher information matrix
is the log-likelihood of all the observations Y given the population parameters ψ .
170
Assuming independence across subjects, the log-likelihood can be defined as the sum of the 171 individual contribution to the log-likelihood: ( ) ( ) 1 , ,
. Therefore, the population 172
Fisher information matrix (calculated using the second derivative of the log-likelihood) for N subjects 173 can also be defined as the sum of the N elementary information matrices ( )
In the case of a limited number of L groups (where each individual in a group share the same design), 177 as in Equation (3), the population FIM is expressed by: 
is the block of the Fisher matrix for the fixed effects β and 184 ( )
λ ξ = is the block of the Fisher matrix for the variance components λ .
185
When a standard FO approximation of the model is performed (see appendix), then the distribution 186 of the observations in patient i with design ξ i is approximated by
Expressions for the 187 population mean i E and population variance i V are given in the appendix. Then the following 188 expression for blocks A, B and C are obtained (18, 30, 31), ignoring indices i for simplicity : 189
This expression of the FIM (eq. 12) will be referred to as the full FIM in this paper. 194
If the approximated variance V is assumed independent of the typical population parameters β , the 195 matrix C will be zero and the matrices A and B will instead be defined as: 196
which will be termed the block diagonal FIM in the following. The explicit formula for ( )
using the block diagonal form is given in the appendix. More information about the derivation of the 201 FIM or other approximations are reported in (27, 28, 30, (32) (33) (34) Comparison of software for design evaluation 229 As we focus on design evaluation and not design optimisation, we first compared the software tools 230 with respect to a) required programming language, b) availability, c) library of PK and PD models, and 231 ability to deal with: d) multiple response models, e) models defined by differential equations, e) 232 unbalanced multiple response designs, f) correlations between random effects and/or residuals, g) 233 models including inter-occasion variability, h) models including fixed effects for the influence of 234 discrete covariates on the parameters, i) computation of the predicted power. Table 1 is a summary 235 of the comparison of the software with respect to these different aspects. Globally, for all software 236 tools, the library of PK models includes one, two and three compartment models, with bolus, 237 infusion and first-order (e.g. oral) administration, after a single dose, multiple doses and at steady 238 state. PK models with first-order elimination and models Michaelis-Menten elimination are available. 239
Regarding PD models, immediate linear and Emax models and turnover response models are 240 available. 241
Over recent years, those tools have included various improvements in terms of model specification 242 and calculations of the FIM. For all of them, design evaluation can be performed for single or multiple 243 response models either using libraries of standard PK and PD models or using a user-defined model. 244
For the latter, regardless of the software used, the model can be written using an analytical form or 245 using a differential equation system. In the case of multiple response models, population designs can 246 Two different examples were used to illustrate the performance of the five population design 262 software tools. Note that the examples evaluated the prediction for a given design, by evaluating the 263 FIM and the predicted asymptotic SEs, without design optimisation. This was done to evaluate the 264 core calculations of the FIM. The FIM is evaluated with the full and the block diagonal derivation (eq. 265 12, 13) with the different software tools. 266
In the first example a one compartment PK model (based on a warfarin PK model) with first-order 267 absorption was used ( The HCV model is described by the following system of ODEs: 282
is the drug concentration at time t and r(t) is the constant infusion rate. The 285 viral dynamics model considers target cells, T, productively infected cells, I and viral particles, W. 286
Target cells are produced at a rate s and die at a rate d. Cells become infected with de-novo infection 287 rate e. After infection, these cells are lost with rate δ. In the absence of treatment, virus is produced 288 by infected cells at a rate p and cleared at a rate c, for more details see (38, 39) and their values are listed in Table 3 . 296 297 Methods 298 299 For each example using each software tool, we computed the FIM based on the FO linearisation, 300
given the parameters and the design. We used both the block-diagonal and the full FIM (not available 301 in POPT). From the FIM, we computed the predicted SE values for each parameter and the 302 13 information D-criterion which is defined as the determinant of the FIM to the power of one over the 303 number of parameters:
To investigate the FIM predictive performance, the empirical SE values were also estimated using 305 CTS. More precisely, for each example, multiple data sets were simulated and then fitted using the 306 Stochastic Approximation Expectation Maximisation (SAEM) algorithm in MONOLIX 2.4 307 (www.lixoft.eu) and, for the PK example also with the FOCEI algorithm in NONMEM 7 308 (http://www.iconplc.com/technology/products/nonmem/). Empirical standard errors were derived 309 from the estimated parameters. The empirical D-criterion was computed from the normalized 310 empirical variance-covariance matrix of all estimated parameters,
. Because the 311 CTS was much more time consuming for the HCV PKPD model, we did not perform the estimation 312 with NONMEM and we did only 500 replicates, whereas we simulated 1000 replicates for the 313 warfarin PK model. 314
For the CTS, to compute the empirical covariance matrix, the full variance-covariance matrix of all the 315 estimated vectors was computed, not as two separate blocks for fixed effects and random 316 components. 317 318 Results 319 320 For the PK model, the results show no differences between the optimal design software tools when 321 evaluating the FIM using the block diagonal and full form. In the same way, all software reported the 322 same expected D-criterion (Figure 1 ), and the same expected relative standard errors (RSE) values 323 expressed in % (Table 4 ). 324
In this example, the block diagonal FIM calculations gave an expected D-criterion that was very 325 similar to the observed D-criterion based on the inverse of the empirical covariance matrix (Figure 1) . 326
However, for all software, the block diagonal D-criterion is slightly smaller than the NONMEM FOCEI 327 based criterion. Note that the result from MONOLIX is lower than the expected D-criterions, in line 328 with theoretical expectations the Cramer-Rao inequality (FIM is an asymptotic upper bound on the 329 information). The full FIM predicts considerably more information compared to the simulations 330 (expected D-criterions are larger than the observed values), and predicts total information that is 331 farther from the empirical values than the block diagonal calculations. The same trends are evident 332 when looking at the RSE values, reported in Table 4 . Good agreement between the CTS and the block 333 14 diagonal FIM was found, while the full FIM predicted considerably higher precision in Ka β and β CL/F
. 335
For the more complicated PKPD model, results are summarized In Figure 2 and Table 5 where RSE (%) 336 are reported. The D-criterion reveals negligible differences between any of the software (Figure 2 ) 337 and also almost no difference between predicted SE values (Table 5 ). In this example, as in the PK 338 example, using the block diagonal FIM gave D-criterion predicted values that were very similar to the 339 D-criterion based on the inverse of the empirical covariance matrix (Figure 2) . The full FIM predicts 340 considerably more information compared to the simulations (expected D-criterions larger than the 341 observed values) and predicts total information (D-criterion) that is farther from the empirical values 342 than the block diagonal calculations. The same trends are evident when looking at SE values for each 343 parameter ( We compared the expression of the FIM computed by the five different optimal design software 354 packages for two examples. The first example was a simple PK model for which the algebraic 355 solution could be written analytically. When using the same approximation, all optimal design 356 software packages achieved the same D-efficiency criterion and predicted RSE values (%). The second 357 example was more complex, had two responses (both PK and PD measurements) and the model was 358 written as a series of five differential equations. For this example, the D-criterion and RSE 359 comparisons revealed negligible differences between software. The differences could potentially be 360 explained by the use of different differential equation solvers, methods of implementing multiple 361 response calculations, methods for computing numerical derivatives, tolerance levels for ODEs and 362 numerical implementations of e.g. matrix inverses and solving of linear systems, etc. These small 363 differences could be seen even across the MATLAB computations of the FIM. In this work we did not 364 impose the same implementation of the various steps across software, hence the importance of the 365 present comparison. 366
367
In both examples the expected SE values from the block diagonal FIM were close to the empirical SE 368 values obtained from CTS. The runtimes for all software tools were a few seconds compared to 369 minutes (warfarin example) or days (HCV example) for the CTS evaluation. Although computational 370 speed has increased dramatically since the 1990's, a significant speed advantage is seen with the 371 developed software tools even without considering design optimisation. For instance for the HCV 372 PKPD model the CTS took several days for one design, so that optimization of doses and sampling 373 times would be difficult. 374
In both examples investigated, the block diagonal FIM calculations give an expected D-criterion that 375 is very similar to the observed D-criterion based on the inverse of the empirical covariance matrix 376 and RSE(%) values for parameter match well. In contrast, the full FIM predicts more information 377 compared to the simulations (expected D-criterions larger than the observed values). More 378 discussion on the assumptions beyond the block or full matrix can be found in (33) together with 379 16 suggestions of other stochastic approaches. It seems that when using a FO approximation for 380 computation of the FIM, linearisation around some fixed values for the fixed effects which are then 381 no longer considered as estimable parameters and therefore corresponds to the block diagonal 382 matrix, provides the best approach. Also higher order approximations to the FIM are available that 383 may give better prediction of RSE(%) values (27) . 384
Results using the simple FO approximation and the block diagonal FIM are very close to those 385 obtained by CTS using both FOCEI and SAEM estimation methods in the two examples. However, 386 since the expected FIM calculation is computing an asymptotically lower bound of the covariance of 387 the parameters, and the calculations are based on approximations, the authors suggest that a CTS 388 study of the proposed final design be performed in order to evaluate the likely performance of the 389 design in the setting in which it is proposed to be used. Since this would be a single CTS at a specified 390 design then this should not be computationally onerous compared to attempting to "optimise" 391 designs using CTS. In addition, using a CTS study of the final design makes it possible to assess the 392 bias which is not evaluated by the FIM. 393 In this first comparison between the software, we did only design evaluation for continuous data and 394 using the simpler FO approximation of the FIM. This first step was necessary before the next work 395 where we will compare results of design optimisation. Indeed now that we know that similar 396 criterion across software are obtained, we can compare the rather different optimisation algorithms 397 implemented. In principle any design variable that is present in the model can be optimised within an 398 optimal design framework. Examples of design variables that can be optimised are measurement 399 sampling times, doses, distribution of subjects between elementary designs, number of 400 measurement samples in an elementary design, etc. How this is done and which design variables can 401 be optimised varies between software, but the independent variable (e.g. measurement sampling 402 times) and the group assignment can be optimised in all software presented in this paper. Results will 403 depend on the assumptions about the model and the parameter values, so that sensitivity studies 404 should be performed to implement 'robust' designs, i.e. designs that are robust to the assumed a 405 priori values of the parameters. Approaches for design optimisation using a priori distribution of the 406 parameters were suggested and implemented for standard nonlinear regression and extended to 407 population approaches and should also be compared in further studies. 408
In conclusion, optimal design software tools allow for direct evaluation of population PKPD designs 409
and are now widely used in industry (25). Choice of software can depend on what platform the user 410 has available and what features they are looking since the FIM calculation in the different software 411
gives similar results. Population approaches are increasingly used and for more complex/ 412 physiological PD models. It is very difficult to guess, without using one of these tools, what are the 413 good designs for those complex ODE models and whether the study will be reliable. We suggest that 414 before performing any population PKPD study, the design should be evaluated with a good balance 415 between the approach based on the Fisher Matrix (for optimising the design) and CTS (for evaluating 416 the final design). 
As there is no analytical expression for the log-likelihood ( )
for nonlinear models, a first-order 428
Taylor expansion around the expectation of i b is used:
Then equation (16) can be approximated as: 431 0 ( ( , ), ) ( ( , 0), ) ( ( , 0), , ) 
is the variance of ( ( , 0), , ) 2 PD σ : residual variance for the PD response. Figure 1 . D-criterion predicted by the different software tools for the warfarin PK model compared to simulated D-criterion calculated from the inverse of the empirical covariance matrix.
Figures
NM FOCEI is calculated from the estimates using the first-order conditional estimation method with interaction in NONMEM. The Monolix criterion is calculated from the estimates using the SAEM algorithm in Monolix. 
